BankInvest Group

MapsPeople develops a cloud-based SaaS platform for indoor navigation in large buildings. Its primary product, MapsIndoors, is used across 50 countries to optimize building functionality, enhance accessibility, and improve visitor navigation. The company generates revenue through MapsIndoors subscriptions, Google Maps licensing, and additional services.

OrderYOYO is a European technology company that specializes in providing an online ordering system tailored specifically for restaurants and takeaways. Its platform includes a branded website, mobile applications for iOS and Android, and comprehensive order, payment, and menu management systems. By integrating business intelligence and user data analytics, OrderYOYO enables restaurants to optimize their operations and marketing efforts. The company also offers tools for social media promotion, email marketing, and Google optimization, helping clients to reach new customers and convert them to direct orders. With a strong presence in the UK, Germany, Denmark, Ireland, and Austria, OrderYOYO aims to enhance profitability for its restaurant partners through its usage-based SaaS solutions and dedicated B2B customer support.

MedTrace Pharma A/S, founded in 2015 and based in Kongens Lyngby, Denmark, specializes in the development of innovative solutions for positron emission tomography (PET) imaging. The company has created an automated system, known as MT-100, which efficiently produces and injects 15O-water, a radioactive tracer essential for enhanced imaging. This system is designed to integrate seamlessly with in-house cyclotrons and PET scanners, significantly increasing the sensitivity of patient analysis while improving throughput by up to four times compared to conventional methods. Additionally, MedTrace Pharma develops the aQuant analytical platform, which aids in interpreting PET scan results, further optimizing the diagnostic process. With additional offices in Boston, Massachusetts, and Uppsala, Sweden, MedTrace is focused on advancing the capabilities of clinical imaging through automation and innovative technology.

Visiopharm specializes in AI-based image analysis tools for the pathology industry. Founded in 2001, it offers end-to-end digital pathology solutions, including scanners and software with ready-to-use AI apps for diagnostic and research purposes. Its products are used globally by biopharmaceutical companies, CROs, hospitals, and academic institutions.

Iosil Energy Corporation, founded in 2007 and based in Groveport, Ohio, specializes in the production and marketing of high-purity solar grade polysilicon, a crucial raw material for solar cells. The company efficiently leverages waste materials, specifically the byproducts generated from wafer sawing operations, to manufacture its polysilicon. This innovative approach not only reduces costs but also minimizes energy consumption and equipment requirements during production. In addition to its manufacturing capabilities, Iosil Energy's research and development facilities, located at the National Institute for Nanotechnology in Edmonton, Alberta, focus on improving purification technologies for silicon, contributing to the advancement of sustainable energy solutions.

Enecsys Limited is a company specializing in the development, manufacturing, and marketing of advanced solar micro inverters and monitoring systems. These products are designed to convert direct current (DC) from solar modules into clean alternating current (AC) for integration into the electricity grid. Enecsys micro inverters are known for their ability to maximize energy harvest, enhance safety, and provide improved reliability and performance monitoring. The company's monitoring system allows for real-time tracking of each photovoltaic module's performance through a robust wireless communication network that connects to the Internet. Headquartered in Cambridge, UK, Enecsys also maintains sales and support offices in Germany, the USA, and Taiwan, serving both residential and commercial markets.

Nujira is a company specializing in power amplifier technology for the wireless communications industry. They develop High Accuracy Tracking (HAT) Power Modulators designed to enhance the efficiency and flexibility of base stations, transmitters, and cellular terminals. Their technology supports various standards including 3G, evolved 3G, DVB, and WiMAX, enabling equipment vendors to create smaller, more cost-effective solutions that meet the growing demands of operators and broadcasters globally. Nujira holds over 200 patents related to envelope tracking technology, which is crucial for powering energy-efficient fourth-generation cellular devices.

SulfurCell is a German developer and manufacturer of thin-film, electricity-generating solar modules. Sulfurcell's thin-film modules have demonstrated some of the highest energy conversion efficiencies for thin-film PV. Sulfurcell's product also offers scalability — a crucial component for high-volume supply — bringing the solar industry one step closer to mainstream applications.

CamSemi is a privately-held, fabless company based in Cambridge, UK, helping customers find faster, lower cost and easier ways to design and manufacture more energy-efficient power conversion products. CamSemi’s products are based on its portfolio of patented, proprietary technologies and topologies including intelligent control architectures, RDFC and PowerBrane. These new approaches can benefit multiple markets although initially the company is targeting two major opportunities: high-volume mains power supplies and lighting applications.

Santaris Pharma A/S is a privately held clinical-stage biopharmaceutical company based in Denmark, specializing in the discovery and development of RNA-targeted therapies. Utilizing its proprietary Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine, the company focuses on delivering potent single-stranded LNA-based drug candidates for various disease states. Santaris Pharma's research and development efforts primarily target infectious diseases and cardiometabolic disorders, while also engaging in partnerships with major pharmaceutical companies to address a broader range of therapeutic areas, including cancer, cardiovascular disease, and rare genetic disorders. Founded in 2003, the company holds exclusive worldwide rights for the manufacture and sale of products containing LNA as an active ingredient, supporting its goal of obtaining marketing approval for its innovative therapies.

Atraverda is an advanced material company that owns the intellectual property rights to a conductive ceramic known worldwide through its trademark, Ebonex®.

Borean Pharma ApS operates as a drug discovery and development company. The company's technology platform enables to design, develop, and produce pharmaceutical protein products. The company focuses on recombinant protein technology, as well as on antibody biopharmaceuticals. It offers protein products, antibody analogues, and CTLD library, as well as TNF antagonist for rheumatoid arthritis. The company was founded in 1997 and is based in Aarhus, Denmark.

Altus Pharmaceuticals is an information technology consulting firm that serves a diverse range of clients, including healthcare providers, manufacturing companies, and financial institutions. The firm positions itself as a strategic partner, providing expertise to help organizations navigate complex challenges and enhance their operational efficiency. With a focus on delivering impactful solutions, Altus aims to support its clients in achieving their goals while addressing the unique demands of their respective industries.

BioStratum, Inc. is a biotechnology company based in Durham, North Carolina, specializing in the development and commercialization of therapeutic agents aimed at treating diabetes and its complications. Founded in 1994, BioStratum focuses on scientific advancements related to the basal lamina and its associated technologies. The company's product portfolio includes Pyridorin, a small molecule drug designed for the treatment of diabetic kidney disease, alongside pre-clinical compounds addressing both diabetic complications and cancer. By targeting novel extracellular components of the basal lamina, BioStratum aims to improve wound repair and promote tissue regeneration, ultimately enhancing patient outcomes in degenerative and invasive disease processes.

Acadia Pharmaceuticals is a biopharmaceutical company dedicated to developing and commercializing small molecule drugs targeting unmet medical needs in central nervous system disorders. Its primary product, NUPLAZID (pimavanserin), treats hallucinations and delusions associated with Parkinson's disease psychosis.

Acadia Pharmaceuticals is a biopharmaceutical company dedicated to developing and commercializing small molecule drugs targeting unmet medical needs in central nervous system disorders. Its primary product, NUPLAZID (pimavanserin), treats hallucinations and delusions associated with Parkinson's disease psychosis.